Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 46 out of 100. Brain scans and imaging

Topic: Amyloid, tau and blood-test diagnosis

Traditional diagnostic methods for Alzheimer's disease often suffer from low accuracy and lengthy processing times, delaying crucial interventions and patient care. Deep convolutional neural networks trained on MRI data can enhance diagnostic precision. This study aims to utilize deep convolutional neural networks (CNNs) trained on MRI data for Alzheimer's disease diagnosis and classification. In this study, the Alzheimer MRI Preprocessed Dataset was used, which includes 6735 brain structural MRI scan images. After data preprocessing and normalization, four models Xception, VGG19, VGG16 and InceptionResNetV2 were utilized. Generalization and hyperparameter tuning were applied to improve training. Early stopping and dynamic learning rate were used to prevent overfitting. Model performance was evaluated based on accuracy, F-score, recall, and precision. The InceptionResnetV2 model showed superior performance in predicting Alzheimer's patients with an accuracy, F-score, recall, and precision of 0.99. Then, the Xception model excelled in precision, recall, and F-score, with values of 0.97 and an accuracy of 96.89. Notably, InceptionResnetV2 and VGG19 demonstrated faster learning, reaching convergence sooner and requiring fewer training iterations than other models. The InceptionResNetV2 model achieved the highest performance, with precision, recall, and F-score of 100% for both mild and moderate dementia classes. The Xception model also performed well, attaining 100% for the moderate dementia class and 99-100% for the mild dementia class. Additionally, the VGG16 and VGG19 models showed strong results, with VGG16 reaching 100% precision, recall, and F-score for the moderate dementia class. Deep convolutional neural networks enhance Alzheimer's diagnosis, surpassing traditional methods with improved precision and efficiency. Models like InceptionResnetV2 show outstanding performance, potentially speeding up patient interventions.

Key findings

Why it matters

This study compared several deep learning models for classifying Alzheimer's disease from MRI images and found InceptionResNetV2 achieved the highest performance. It is a technical classification study and does not test any treatment, cure, or prevention.

Study details

How this study scored 46/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 3 of 7; Citations per year 3 of 5; Impact for its field and year 5 of 6; Cited by studies here 1 of 6; Still being cited 2 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 46 of 100.46 of 100 points earned54 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Scientific Reports)
Journal's citation record 3 / 4 Scientific Reports: journal h-index 463 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 3 / 7 Cited 33 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 11.0 citations a year over 3 year(s) since 2025
Impact for its field and year 5 / 6 Cited 21.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 2 / 4 Cited 33 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Leila Ahmadian: h-index 24 (OpenAlex, whole career)
Institution's track record 0 / 3 Iran University of Medical Sciences: institution h-index 349 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40594827)
Free to read 2 / 2 Free to read
Total 46 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Mousavi, S. M., Moulaei, K., & Ahmadian, L. (2025). Classifying and diagnosing Alzheimer’s disease with deep learning using 6735 brain MRI images. Scientific Reports. https://doi.org/10.1038/s41598-025-08092-1

Vancouver

Mousavi SM, Moulaei K, Ahmadian L. Classifying and diagnosing Alzheimer’s disease with deep learning using 6735 brain MRI images. Scientific Reports. 2025. doi:10.1038/s41598-025-08092-1. PMID: 40594827.

BibTeX

@article{mousavi2025-40594827,
  author  = {Mousavi, Seyed Mohammad and Moulaei, Khadijeh and Ahmadian, Leila},
  title   = {{Classifying and diagnosing Alzheimer’s disease with deep learning using 6735 brain MRI images}},
  journal = {Scientific Reports},
  year    = {2025},
  doi     = {10.1038/s41598-025-08092-1},
  pmid    = {40594827},
  url     = {https://doi.org/10.1038/s41598-025-08092-1}
}

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Brain scans and imaging

Similar studies

More on Brain scans and imaging

See all studies in Brain scans and imaging →